unknown
Stage
1
Investors
About
Vortex develops a CTC isolation platform that combines high-performance engineering with clinical simplicity, delivering high-purity circulating tumor cells (CTCs) ready for downstream analysis to advance precision medicine in cancer detection and monitoring.
Explore Vortex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.